SUVN-G3031, A NOVEL, POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR INVERSE AGONIST FOR THE TREATMENT OF NARCOLEPSY: PRECLINICAL CHARACTERIZATION

被引:0
|
作者
Bhayrapuneni, Gopinadh [1 ]
Kamuju, Venkatesh [1 ]
Gandipudi, Sudhakar [1 ]
Jayarajan, Pradeep [1 ]
Abraham, Renny [1 ]
Bojja, Kumar [1 ]
Pandey, Santosh Kumar [1 ]
Mekala, Venkat Reddy [1 ]
Nirogi, Ramakrishna [1 ]
机构
[1] Suven Life Sci Ltd, Hyderabad, Telangana, India
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
0120
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Acrylamide compounds as potent and selective histamine H3 receptor ligands
    Nirogi, Ramakrishna
    Shinde, Anil
    Mohammed, Abdul Rasheed
    Kota, Laxman
    Tiriveedhi, Vinaykumar
    Saraf, Sangram
    Subramanian, Ramkumar
    Bhyrapuneni, Gopinadh
    Benade, Vijay
    Muddana, Nageswararao
    Jayrajan, Pradeep
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [42] Conjugated amides: Potent and selective histamine H3 receptor ligands
    Nirogi, Ramakrishna
    Shinde, Anil
    Mohammed, Abdul Rasheed
    Saraf, Sangram Keshri
    Bojja, Kumar
    Achanta, Pramodkumar
    Sastry, Kambhampati
    Subramanian, Ramkumar
    Bhyrapuneni, Gopinadh
    Muddana, Nageswara Rao
    Jayarajan, Pradeep
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [43] Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity
    Sundar, Babu G.
    Bailey, Thomas R.
    Dunn, Derek
    Hostetler, Greg A.
    Chatterjee, Sankar
    Bacon, Edward R.
    Yue, Christoph
    Schweizer, Dominique
    Aimone, Lisa D.
    Gruner, John A.
    Lyons, Jacquelyn
    Raddatz, Rita
    Lesur, Brigitte
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (04) : 1546 - 1549
  • [44] Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand
    Witte, David G.
    Yao, Betty Bei
    Miller, Thomas R.
    Carr, Tracy L.
    Cassar, Steven
    Sharma, Rahul
    Faghih, Ramin
    Surber, Bruce W.
    Esbenshade, Timothy A.
    Hancock, Arthur A.
    Krueger, Kathleen M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) : 657 - 670
  • [45] Synthesis and Evaluation of Structurally Constrained Quinazolinone Derivatives as Potent and Selective Histamine H3 Receptor Inverse Agonists
    Nagase, Tsuyoshi
    Mizutani, Takashi
    Sekino, Etsuko
    Ishikawa, Shiho
    Ito, Sayaka
    Mitobe, Yuko
    Miyamoto, Yasuhisa
    Yoshimoto, Ryo
    Tanaka, Takeshi
    Ishihara, Akane
    Takenaga, Norihiro
    Tokita, Shigeru
    Sato, Nagaaki
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (21) : 6889 - 6901
  • [46] Procognitive potential of novel aryl and heteroaryl amides as potent and selective histamine H3 receptor antagonists
    Nirogi, Ramakrishna
    Shinde, Anil
    Deshpande, Amol
    Dwarampudi, Adireddy
    Gangadasari, Pamuleti Narasimhareddy
    Gudla, Parandhama
    Kota, Laxman
    Gampa, Muralimohan
    Kodru, Padmavathi
    Tiriveedhi, Vinaykumar
    Saraf, Sangram K.
    Shaik, Mohammad
    Badange, Rajeshkumar
    Bojja, Kumar
    Balasubramaniam, Suresh
    Faheem, Mohammed
    Kandikere, Vishwottam
    Jayarajan, Pradeep
    Muddana, Nageswararao
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [47] Discovery of novel amides: Highly potent and selective histamine H3 receptor antagonists and their procognitive potential
    Nirogi, Ramakrishna
    Shinde, Anil
    Dwarampudi, Adireddy
    Deshpande, Amol
    Kambhampati, Ramasastry
    Kota, Laxman
    Gampa, Muralimohan
    Kodru, Padmavathi
    Tiriveedhi, Vinaykumar
    Saraf, Sangram Keshri
    Kandikere, Vishwottam
    Abraham, Renny
    Shanmuganathan, Dhanalakshmi
    Murthy, Patnala
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [48] Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
    T. A. Esbenshade
    B. B. Yao
    D. G. Witte
    T. L. Carr
    R. Sharma
    J. L. Baranowski
    K. M. Krueger
    T. R. Miller
    B. W. Surber
    R. Faghih
    A. A. Hancock
    Inflammation Research, 2005, 54 : S46 - S47
  • [49] Use of novel, non-imidazole inverse agonist radioligands to define histamine H3 receptor pharmacology
    Esbenshade, TA
    Yao, BB
    Witte, DG
    Carr, TL
    Sharma, R
    Baranowski, JL
    Krueger, KM
    Miller, TR
    Surber, BW
    Faghih, R
    Hancock, AA
    INFLAMMATION RESEARCH, 2005, 54 (Suppl 1) : S46 - S47
  • [50] Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivo
    Shih, NY
    Aslanian, R
    Lupo, AT
    Orlando, S
    Piwinski, JJ
    Green, MJ
    Ganguly, AK
    West, R
    Tozzi, S
    Kreutner, W
    Hey, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (03) : 243 - 248